The global embolic protection devices market size is expected to reach USD 1.09 billion by 2030, according to a new report by Grand View Research, Inc. The market is estimated to expand at a CAGR of 8.7% from 2024 to 2030. Rising incidences of cardiovascular and neurovascular diseases and growing adoption of minimally invasive diseases are propelling the market growth. Rising demand for technologically advanced embolic devices and increasing healthcare expenditure, resulting in huge funding and investments from multinational companies, are fueling the R&D in the global medical devices industry. This factor is also contributing toward the market growth.
On the other hand, the product failures and recalls may limit the market growth. Low reimbursement for stenting and presence of alternative treatment methods, such as the use of drugs, may also imped the market development. However, factors such as a rise in the number of Trans-catheter Aortic Valve Replacement (TAVR) procedures will support the market expansion.
Request a free sample copy or view report summary: Embolic Protection Devices Market Report
Distal filter devices segment emerged as the largest segment owing to high demand for these devices
Neurovascular diseases accounted for the largest share in the application segment owing to the rising cases of neurological disorders
North America led the global embolic protection devices market with the largest share in 2023 and is likely to maintain this trend over the estimated period
Growing adoption of minimally invasive surgeries and increasing demand for novel technologies are facilitating the dominance of this region
The industry in the Asia Pacific is projected to witness swift growth during the forecast period owing to rapidly improving healthcare infrastructure and large target population base
Grand View Research has segmented the global embolic protection devices market report based on product, application, and region:
Embolic Protection Devices Product Outlook (Revenue, USD Million, 2018 - 2030)
Distal Occlusion Devices
Proximal Occlusion Devices
Distal Filters
Embolic Protection Devices Application Outlook (Revenue, USD Million, 2018 - 2030)
Cardiovascular Diseases
Neurovascular Diseases
Peripheral Vascular Diseases
Embolic Protection Devices Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Mexico
Canada
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
South Korea
Thailand
Australia
Latin America
Brazil
Argentina
MEA
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players of Embolic Protection Devices Market
Boston Scientific Corporation
Edwards Lifesciences Corporation.
Abbott.
Medtronic
Cardinal Health.
Innovative Cardiovascular Solutions, LLC
Transverse Medical, Inc.
W. L. Gore & Associates, Inc.
"The quality of research they have done for us has been excellent..."